Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/19230
Title: SYNTHESIS AND CHARACTERIZATION OF PALLADIUM (II)–2- (AZIDOMETHYL)CYCLOPROPANE-1,1-DICARBOXYLIC ACID COMPLEX
Authors: Kostic, Marina
Divac, Vera
Mangelinckx, Sven
Issue Date: 2021
Abstract: The discovery that palladium complexes possess a wide range of biological activities (from antitumor, -viral, -malarial, -fungal to antimicrobial activities) encourages further research in this scientific field. Herein we describe the synthesis and characterization of a novel palladium (II) complex, using [Pd(dien)Cl]Cl and 2-(azidomethyl)cyclopropane-1,1-dicarboxylic acid (azmcpda) as a ligand. [Pd(dien)Cl]Cl was selected as a starting material taking into consideration its importance as a model for the investigation of the substitution reactions in coordination chemistry and a deeper understanding of the biological activities of some structurally similar compounds. The ligand compound was synthesized by the procedure described in the literature. It is noteworthy to mention that 2- (azidomethyl)cyclopropane-1,1-dicarboxylic acid presents the precursor for the synthesis of 2- (aminomethyl)cyclopropane-1,1-dicarboxylic acid, as an example of the constrained γ-amino dicarboxylic acids. The synthesis was achieved by the conversion of the ligand compound into the corresponding sodium dicarboxylate salt and subsequent treatment with [Pd(dien)Cl]Cl (pH maintained between 6-7). The IR and NMR spectra, as well as elemental analysis have confirmed that the Na[Pd(dien)(azmcpda)]. H2O species was formed and that coordination of the ligand compound to the metal ion was established through carboxylate oxygen donor atom.
URI: https://scidar.kg.ac.rs/handle/123456789/19230
Type: conferenceObject
DOI: 10.46793/ICCBI21.297K
Appears in Collections:Institute for Information Technologies, Kragujevac

Page views(s)

14

Downloads(s)

2

Files in This Item:
File Description SizeFormat 
ICCBIKG 2021.pdf443.51 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons